ADYNOVATE DIN 02459043
Status: Dormant
Holder: TAKEDA CANADA INC
Available to quote
Health Canada record
| Active ingredient(s) | ANTIHEMOPHILIC FACTOR (RECOMBINANT), PEGYLATED 500 UNIT |
|---|---|
| Dosage form | Powder For Solution; Kit |
| Route | Intravenous |
| Schedule | SCHEDULE D |
| Class | Human |
| ATC | B02BD02 COAGULATION FACTOR VIII |
| Original market date | 06-Mar-2018 |
| Current status date | 15-Jan-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Takeda Canada Inc. — licence 101769, currently licensed, last inspection rating C (2026-02-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ANTIHEMOPHILIC FACTOR (RECOMBINANT), PEGYLATED
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02459078 | ADYNOVATE | TAKEDA CANADA INC | Kit; Powder For Solution | ANTIHEMOPHILIC FACTOR (RECOMBINANT), PEGYLATED 2000 UNIT | Marketed |
| 02498537 | ADYNOVATE | TAKEDA CANADA INC | Powder For Solution; Kit | ANTIHEMOPHILIC FACTOR (RECOMBINANT), PEGYLATED 250 UNIT | Marketed |
| 02498545 | ADYNOVATE | TAKEDA CANADA INC | Powder For Solution; Kit | ANTIHEMOPHILIC FACTOR (RECOMBINANT), PEGYLATED 500 UNIT | Marketed |
| 02498553 | ADYNOVATE | TAKEDA CANADA INC | Kit; Powder For Solution | ANTIHEMOPHILIC FACTOR (RECOMBINANT), PEGYLATED 750 UNIT | Approved |
| 02498561 | ADYNOVATE | TAKEDA CANADA INC | Powder For Solution; Kit | ANTIHEMOPHILIC FACTOR (RECOMBINANT), PEGYLATED 750 UNIT | Approved |
| 02498588 | ADYNOVATE | TAKEDA CANADA INC | Powder For Solution; Kit | ANTIHEMOPHILIC FACTOR (RECOMBINANT), PEGYLATED 1000 UNIT | Marketed |
| 02498596 | ADYNOVATE | TAKEDA CANADA INC | Kit; Powder For Solution | ANTIHEMOPHILIC FACTOR (RECOMBINANT), PEGYLATED 1500 UNIT | Marketed |
| 02498618 | ADYNOVATE | TAKEDA CANADA INC | Kit; Powder For Solution | ANTIHEMOPHILIC FACTOR (RECOMBINANT), PEGYLATED 1500 UNIT | Approved |
| 02498626 | ADYNOVATE | TAKEDA CANADA INC | Kit; Powder For Solution | ANTIHEMOPHILIC FACTOR (RECOMBINANT), PEGYLATED 3000 UNIT | Marketed |
| 02459035 | ADYNOVATE | TAKEDA CANADA INC | Powder For Solution; Kit | ANTIHEMOPHILIC FACTOR (RECOMBINANT), PEGYLATED 250 UNIT | Dormant |
| 02459051 | ADYNOVATE | TAKEDA CANADA INC | Powder For Solution; Kit | ANTIHEMOPHILIC FACTOR (RECOMBINANT), PEGYLATED 1000 UNIT | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 25021 | 2021-01-15 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBER (DIN). LABELLING UPDATES |
| 20774 | 2018-04-20 | New Drug Submission (NDS) | MERGER - BUYOUT |
| 18666 | 2016-11-17 | New Drug Submission (NDS) |